$2.600
-0.040 (-1.52%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CRVO Prediction & Forecast by Similar Chart Analysis
Alphio's CRVO stock price prediction model matches the current CervoMed Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.60 (-0.12%). The 1-week path is $2.63 (+1.11%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy CervoMed Inc Stock?
CervoMed Inc is not a good buy right now due to its current price of $2.60, which is significantly below the analyst price target of $7 from Roth Capital. Additionally, the stock has a low RSI of 37.007, indicating it is nearing oversold conditions, but the overall trend remains negative with a year-to-date change of -66.62%. The main risk is the company's ongoing financial losses, with a net income of -6,571,656 USD reported for Q2 2026, which raises concerns about its sustainability and ability to fund future trials.
CRVO stock price ended at $2.60 on Friday, after losing -1.52%
CervoMed Inc (CRVO) last closed at $2.6, losing -1.52%. These facts feed the 1-day and 1-week CRVO price prediction above.
Forecast Drivers
CervoMed Inc (CRVO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CRVO, ranked by similarity.
Seasonality analysis for CRVO
Historically the probability of a positive August return for CRVO is 68.25%. September offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.